Immediate Impact
12 standout
Citing Papers
Accelerating antiviral drug discovery: lessons from COVID-19
2023 Standout
Hepatitis C Guidance 2023 Update: American Association for the Study of Liver Diseases– Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection
2023 Standout
Works of Séverine Gibowski being referenced
Retreatment With Sofosbuvir Plus Grazoprevir/Elbasvir Plus Ribavirin of Patients With Hepatitis C Virus Genotype 1 or 4 Who Previously Failed an NS5A- or NS3-Containing Regimen: The ANRS HC34 REVENGE Study
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Séverine Gibowski | 40 | 9 | 61 | 39 | 8 | 126 | |
| Angela Aramburo | 24 | 25 | 48 | 6 | 10 | 172 | |
| Kathryn Macomber | 31 | 8 | 48 | 42 | 9 | 173 | |
| Julie Timsit | 115 | 101 | 30 | 82 | 9 | 244 | |
| Nils Postel | 153 | 10 | 96 | 5 | 9 | 245 | |
| F. B. Vezinet | 126 | 79 | 51 | 9 | 8 | 182 | |
| Kathrin Keeren | 99 | 45 | 55 | 6 | 12 | 163 | |
| Jane Hecht | 44 | 6 | 55 | 8 | 7 | 158 | |
| Bénédicte Poll | 89 | 68 | 36 | 70 | 6 | 192 | |
| Daniela Segala | 56 | 32 | 62 | 6 | 15 | 165 | |
| Anna Favia | 102 | 65 | 63 | 26 | 6 | 143 |
All Works
Loading papers...